Skip to main content
Clinical Trials/JPRN-jRCTs051220122
JPRN-jRCTs051220122RecruitingPhase 4

Preventive effect of active Protocol-Based Pharmacotherapy Management for delirium in general wards of emergency department: A Single-Center, Randomized Controlled Trial - aPBPM trial

Ohtsuru Shigeru0 sites105 target enrollmentStarted: November 25, 2022Last updated:
Conditions

Trial Snapshot

Phase
Phase 4
Status
Recruiting
Sponsor
Enrollment
105

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
>= 65age old to ot applicable (—)
Sex
All

Inclusion Criteria

  • 1) Patients who are admitted to the general ward of the department of primary care and emergency medicine from the emergency room between 8:30 and 17:00 on weekdays.
  • 2) One or more of the following six risk factors for developing delirium: central nervous system disease, cognitive dysfunction, history of high alcohol intake, history of delirium, use of drugs at risk of delirium, Post-surgery or scheduled surgery requiring general anesthesia.
  • 3) Patients over 65 years old.

Exclusion Criteria

  • 1) Patients with schizophrenia
  • 2) Patients taking antipsychotics.
  • 3) Patients who cannot be hospitalized for more than48 hours.
  • 4) Patients taking benzodiazepines prescribed by a psychiatrist or psychosomatic physician
  • 5) Patients taking CYP3A4 inhibitors (itraconazole, clarithromycin, erythromycin, fluconazole, verapamil, HIV protease inhibitor, etc.)
  • 6) Patients taking Ramelteon or lemborexant
  • 7) Blonanserin patch is applied
  • 8) Patients with severe liver dysfunction
  • 9) Patients with severe disturbance of consciousness
  • 10) Sedatives are used before the start of the study
  • 11) Patients with drug abuse

Investigators

Sponsor
Ohtsuru Shigeru

Similar Trials